Hydrocortamate
Magnacort (hydrocortamate) is a small molecule pharmaceutical. Hydrocortamate was first approved as Magnacort on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Hydrocortamate hydrochloride
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MAGNACORT | Mylan | N-010554 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
84 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pain | D010146 | EFO_0003843 | R52 | 4 | 7 | 5 | 5 | 2 | 23 |
Postoperative pain | D010149 | G89.18 | — | — | 1 | 4 | 1 | 6 | |
Chronic pain | D059350 | HP_0012532 | — | — | 3 | 2 | — | 5 | |
Postoperative nausea and vomiting | D020250 | EFO_0004888 | — | — | — | 1 | 1 | 2 | |
Rotator cuff injuries | D000070636 | M75.1 | — | 1 | — | 1 | — | 2 | |
Pain management | D059408 | — | — | — | 2 | — | 2 | ||
Toothache | D014098 | K08.89 | — | — | — | 1 | 1 | 2 | |
Rib fractures | D012253 | — | — | — | 1 | — | 1 | ||
Colonic neoplasms | D003110 | C18 | — | — | — | 1 | — | 1 | |
Rectal neoplasms | D012004 | — | — | — | 1 | — | 1 |
Show 19 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Low back pain | D017116 | HP_0003419 | M54.5 | — | 1 | 4 | — | 1 | 6 |
Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | 1 | 1 | — | — | 2 |
Anterior cruciate ligament injuries | D000070598 | — | 1 | 1 | — | — | 1 | ||
Shoulder pain | D020069 | HP_0030834 | M25.51 | — | — | 1 | — | — | 1 |
Multiple myeloma | D009101 | C90.0 | — | — | 1 | — | — | 1 | |
Lymphoma | D008223 | C85.9 | — | — | 1 | — | — | 1 | |
Head and neck neoplasms | D006258 | — | — | 1 | — | — | 1 | ||
Mucositis | D052016 | EFO_1001898 | — | — | 1 | — | — | 1 | |
Vomiting | D014839 | HP_0002013 | R11.1 | — | — | 1 | — | — | 1 |
Nausea | D009325 | HP_0002018 | R11.0 | — | — | 1 | — | — | 1 |
Show 4 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Musculoskeletal pain | D059352 | 1 | 1 | — | — | — | 2 | ||
Corneal injuries | D065306 | HP_0000559 | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | 5 | — | — | — | — | 5 | ||
Drug interactions | D004347 | 1 | — | — | — | 1 | 2 | ||
Ankle fractures | D064386 | S82.5 | 1 | — | — | — | — | 1 | |
Substance-related disorders | D019966 | EFO_0003890 | F13 | 1 | — | — | — | — | 1 |
Hepatic insufficiency | D048550 | 1 | — | — | — | — | 1 | ||
Renal insufficiency | D051437 | HP_0000083 | N19 | 1 | — | — | — | — | 1 |
Indications Without Phase
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | HYDROCORTAMATE |
INN | hydrocortamate |
Description | Hydrocortamate is a glycinyl ester, an 11beta-hydroxy steroid, a 17alpha-hydroxy steroid, a glucocorticoid, a 3-oxo-Delta(4) steroid and a tertiary alpha-hydroxy ketone. It has a role as an anti-inflammatory drug and an immunosuppressive agent. It is functionally related to a cortisone. |
Classification | Small molecule |
Drug class | cortisone derivatives |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCN(CC)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C |
Identifiers
PDB | — |
CAS-ID | 76-47-1 |
RxCUI | — |
ChEMBL ID | CHEMBL1201263 |
ChEBI ID | 50851 |
PubChem CID | 84088 |
DrugBank | DB00769 |
UNII ID | Y3N00BK5WK (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 8 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
246 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more